Stress Granule (SG) Formation Assay Service
In the complex landscapes of virology, neurodegenerative diseases, and cancer research, understanding stress granule (SG) dynamics is paramount. As a CRO technology pioneer in neurobiology, we offer highly sensitive, multi-dimensional SG formation measurement services. Our cutting-edge techniques provide unparalleled insights into cellular stress responses. For further information regarding the products and services provided, project-specific consultation, and pricing, please submit an inquiry here.
SG Formation in Amyotrophic Lateral Sclerosis (ALS)
There is a strong association between ALS and the formation of SGs. SGs are ribosomal particles formed by cells under stress conditions and consist mainly of untranslated mRNA and RNA-binding proteins (RBPs). These granules play a protective role in the cellular stress response, but their abnormal accumulation and dysfunction may be associated with the development of neurodegenerative diseases such as ALS.
SGs are dynamic cytoplasmic structures that are mainly formed by a phase separation mechanism. TDP-43 is one of the most common pathological features in ALS, and its abnormal accumulation in the cytoplasm is closely related to the formation of SGs. Pathological aggregation of TDP-43 may promote the formation of SGs by inducing endoplasmic reticulum (ER) stress. In addition, TDP-43 mutations also affect the dynamic properties of SGs, making them insoluble and irreversibly aggregated.
Using a 100X objective on a spinning disk confocal microscope, U-2 OS cells expressing GFP-G3BP1 were imaged every 20 seconds for 20 minutes after exposure to 0.5 mM NaAsO2, in order to track stress granule assembly.1
SG Formation Assays
- Stress Treatment Induces SG Formation
Selection of Stress Sources: Common stress inducers include sodium arsenite (0.5-1.0 mM, 30-60 minutes), heat shock (42°C, 20 minutes), oxidative stress (H2O2, 5 mM, 30 minutes), or hyperosmotic stress (1 M KCl, 10 minutes). Different stressors may trigger distinct subtypes of SGs. For example, the composition of SGs induced by heat shock may differ from those induced by oxidative stress.
Verification of Translation Inhibition: Confirming the inhibition of translation initiation is a crucial prerequisite for SG formation. This can be achieved by detecting eIF2α phosphorylation via Western blot (WB) or by using translation inhibitors such as puromycin or cycloheximide.
- Multi-Marker Detection System for SG Analysis
Leveraging fluorescence labeling techniques targeting core SG proteins (e.g., G3BP1, TIA-1, TIAR) and disease-associated proteins (e.g., TDP-43, FUS), this system enables precise analysis of compositional heterogeneity within SGs under various stress conditions, including oxidative stress, heat shock, and viral infection.
- Image Quantification Analysis
To compare the effects of different stress sources, we quantify the number of SGs per cell. Utilize software such as ImageJ or CellProfiler to analyze SG count, size, and distribution. Live-cell imaging techniques, such as confocal microscopy, allow for real-time recording of SG assembly and disassembly processes. This data can be combined with time-series analysis to study SG dynamics.
Fig.1 Time course of stress granule assembly.1
Our stress granule formation assay service offers researchers reliable data support due to its high throughput, high sensitivity, and versatility. Whether in basic research or drug development, our service can help you gain a deeper understanding of the biological functions of stress granules and their role in diseases. Please contact us for more details and to discuss cooperation opportunities.
Reference
- Wheeler, Joshua R., et al. "Distinct stages in stress granule assembly and disassembly." elife 5 (2016): e18413. Distributed under Open Access license CC BY 4.0, without modification.
- iNeuMab™ Anti-EPHB2 Antibody (NRP-0422-P1220) (Cat#: NRP-0422-P1220)
- iNeuMab™ Anti-Amyloid Beta 1-15 Antibody (NRP-0422-P867) (Cat#: NRP-0422-P867)
- iNeuMab™ Mouse Anti-EFNB2 Monoclonal Antibody (CBP1159) (Cat#: NAB-0720-Z4396)
- iNeuMab™ Anti-GD2 Antibody (NRZP-1222-ZP767) (Cat#: NRZP-1222-ZP767)
- iNeuMab™ Anti-TNFα BBB Shuttle Antibody (NRZP-1022-ZP4105) (Cat#: NRZP-1022-ZP4105)
- iNeuMab™ Anti-SEZ6 Antibody (NRP-0422-P517) (Cat#: NRP-0422-P517)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P2275) (Cat#: NRP-0422-P2275)
- iNeuMab™ Mouse Anti-LRP1 Monoclonal Antibody (CBP3363) (Cat#: NAB-0720-Z6479)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P2293) (Cat#: NRP-0422-P2293)
- iNeuMab™ Anti-CD20 Antibody (NRP-0422-P1230) (Cat#: NRP-0422-P1230)
- Mouse Retinal Ganglion Cell Line RGC-5 (Cat#: NCL2110P154)
- Mouse Glioma Cell Line GL-261-Luc (Cat#: NCL-2108P06)
- Mouse Glioma Cell Line GL261-GFP (Cat#: NCL-2108P04)
- Rat Schwann Cells RSC96, Immortalized (Cat#: NCL-2108P21)
- iNeu™ Human Motor Neurons (Cat#: NCL-2103-P71)
- Mouse Retinal Ganglion Cells (Cat#: NCL2110P145)
- Human Retinal Epithelial Cell ARPE-19 (Cat#: NCL2110P069)
- Immortalized Human Cerebral Microvascular Endothelial Cells (Cat#: NCL-2108-P020)
- Human Dental Pulp Stem Cells (Cat#: NRZP-1122-ZP113)
- Mouse Glioma Cell Line GL261 (Cat#: NCL-2108P28)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- AAV2/9-hEF1a-fDIO-eNpHR 3.0-mCherry-WPRE-pA (Cat#: NTA-2012-ZP78)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)